The outlook of companies tied to Sildenafil's history presents a intricate investment scenario . While the initial surge generated substantial gains, generic copies have significantly diminished sales . Investing in connected pharmaceutical businesses now requires a thorough assessment of intellectual property protection , evolving patient trends ,